[HIGHLIGHTS] Pfizer's new crown oral drug has received emergency approval in China. The concept stock has "limited up" ahead of schedule 2022-02-15T08:11:18.024Z Read the full translated version in English Read the full version from chinanews May on the same topic in other locals All business stories on 2022-02-15